EQUITESAN ACULEUS PRODUCT
A pale stone relief of a mounted archer releasing an arrow across a sunlit carved wall.

PLTR / THE CASE BEHIND THE TICKER

See what moved a market.Check the record.

Equites puts a ticker's price action next to the filings, federal contracts, insider activity, and reviewed research that give it context. Start with PLTR. Open the sources yourself.

CASE / 466 SOURCES CHECKEDPLTRPRICE DATA THROUGH 2026-08-21

02 / REAL PRODUCT WALKTHROUGH

Trace the move to the record behind it.

Open PLTR, inspect the historical chart, compare its earnings reactions, and open each primary source inside one reviewed Case.

EQUITESMARKET WORKSPACE
PUBLIC HISTORICAL CASERequest beta access

01 / PRICE

Start with the price move.

HISTORICAL SNAPSHOT · THROUGH 2026-08-21

Featured ticker
PLTR
PLTR · USD$179.94CLOSING PRICE · 2026-08-21
Shown low
$119.50
Shown high
$193.98
Observations
13
CLOSING PRICEselected daily closes
PLTR historical closing price line chartObserved values range from $119.50 to $193.98 across 13 points.

The chart shows what PLTR did. The filings show what changed. Neither proves why the market moved.

Tap or hover to inspect · use arrow keys to move through the record.

13 selected closing observations across 251 Nasdaq sessions. Open Nasdaq history ↗

13 selected observations · source table
Selected PLTR closing prices from the frozen public historical snapshot.
DateClose
2025-08-22$158.74
2025-09-22$179.33
2025-10-22$175.49
2025-11-21$154.85
2025-12-22$193.98
2026-01-22$165.90
2026-02-20$135.24
2026-03-20$150.68
2026-04-22$152.62
2026-05-22$136.88
2026-06-22$119.50
2026-07-22$124.57
2026-08-21$179.94

02 / RECORD

Two releases. Opposite next-session reactions.

SEC FILINGS · Q1 + Q2 2026

Price changed; this record does not claim why. It records the release, the next close, and the linked filing.

Q1 2026

-6.9301% next session

Revenue
+85% YoY
U.S. commercial
+133% U.S. commercial
Close
$146.03 → $135.91
Read Q1 2026 SEC release ↗
Q2 2026

+29.4548% next session

Revenue
+93% YoY
U.S. commercial
+149% U.S. commercial
Close
$125.65 → $162.66
Read Q2 2026 SEC release ↗

The chart shows what PLTR did. The filings show what changed. Neither proves why the market moved.

03 / CASE

Keep the thesis and the counter-case together.

466 SOURCES CHECKED · AS OF 2026-08-23

SUPPORT / PUBLIC CONTRACTS

$997.2M

108 contract actions across the reviewed window. UEI FSY4LVSBGWB7 is the public-money identity in the record.

Open USAspending award ↗

COUNTER / OWNERSHIP FILING

2,000,000 shares sold

Thiel’s sale is dated 2026-03-02; the trading plan was adopted 2025-11-14. The record keeps the sale and its context together.

Open Form 4 index ↗

SOURCES

20 distinct sources cited
  • PLTR PRICE / NASDAQNasdaq · 2026-08-21↗
  • Q1 2026 RESULTS / SECU.S. Securities and Exchange Commission · 2026-05-04↗
  • Q2 2026 RESULTS / SECU.S. Securities and Exchange Commission · 2026-08-03↗

WHAT'S MISSING

Missing inputs stay blank

INVESTOR SENTIMENTNOT SOURCED · No verified sentiment feed was available for this Case.

NEWS FRAMING TONENOT SCORED · The Case captured news sources but did not publish a tone score.

Open the public record now. Request beta access when you want the full research workspace.

Request beta access

PRIVATE BETA / SMALL GROUPS

Request beta access.

Search a ticker. Read the chart. Open the filing. Test the story before you act on it.

Equites is an Aculeus product.